Coronavirus News Roundup: Upcoming MJH COVID-19 Coalition Event, Regeneron and Eli Lilly Request EUA for Antibody Therapies

October 9, 2020

Here's the roundup for this week's coronavirus-related news.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 36,349,500 individuals worldwide, and approximately 7.5 million Americans. The latest COVID-19 related news includes the upcoming MJH Life Sciences COVID-19 Coalition event focused on the treatment landscape, and the dual requests from Regeneron and Eli Lilly for emergency approval for their respective antibody treatments. 

Here’s a roundup of the latest coronavirus-related news:

Pharmacists Garner Priority COVID-19 Vaccination in New Recommendations

The new National Academies of Sciences, Engineering, and Medicine's COVID-19 vaccine recommendations identify pharmacists as one of the essential groups that should be the first to receive the vaccines when they are available.

Read more

Regeneron, Eli Lilly Both Request Emergency Approval for COVID-19 Antibody Therapies

Both Regeneron and Eli Lilly have filed for emergency use authorization from the FDA for each of their investigational antibody therapies for the treatment of COVID-19.

Read more

Navigating the COVID-19 Treatment Landscape: Clinical Controversies Explained

On Tuesday, October 13, MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Navigating the COVID-19 Treatment Landscape: Clinical Controversies Explained” at 6 PM EDT.

Register for the webinar

Election 2020: What Pharmacy Needs from the Next Administration

Scope of practice and vaccination authority don’t usually grab much public attention. But when the US Department of Health & Human Services preempted state practice acts to allow all pharmacists to order and provide COVID-19 tests and provide routine pediatric immunizations, the profession hit the headlines. What happens next in health care depends largely on COVID-19, especially in light of the breaking news at press time that the President has been diagnosed with COVID-19. And then, of course, on the 2020 presidential election itself.

Read more